EUVIMEDEUVIMED entdecken
Crossref

Unified hybrid RNA-regulated CRISPR diagnostic for concurrent Mycobacterium tuberculosis detection and rifampicin resistance profiling

Xinggui Yang, Xiaoyan Zeng, Guorong Qi, Jiangfei Wang, Xiaoyu Wei, Qianfang Hu, Junfei Huang, Yijiang Chen, Yaxing Xie, Ying Li, Yuting Zhong, Shijun Li und 1 weitere

Biosensors and Bioelectronics · 2027-01 · 316 · 119329

DOI: 10.1016/j.bios.2026.119329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-01. Verfasst von Xinggui Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, …. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Rifampin, Drug Resistance, Bacterial, Biosensing Techniques. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality, Science and Technology Planning Project of Yuzhong District of Chongqing City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-based nucleic acid detection is challenged by protospacer adjacent motif (PAM) dependency, amplicon consumption and single-tube multiplexing barriers, and poor discrimination of single-nucleotide variations (SNVs). These limitations are particularly acute in detecting Mycobacterium tuberculosis (MTB) and rifampicin (RIF) resistance mutations for tuberculosis (TB) diagnostics. Herein, we devised TB-SCANER, a broad-spectrum, one-pot CRISPR-Cas12a diagnostic platform for MTB detection and RIF resistance profiling. The assay employs two unlocking single-stranded RNAs (uLsRNAs) transcribed from RPA products to unlock four cis-cleavage-locked CRISPR-Cas12a systems via distinct locking single-stranded RNAs (LsRNAs), establishing a two-to-four hybrid logic: one uLsRNA carries a single unlocking module for the M channel (targeting mpb64 gene), whereas the other contains three tandem modules engaging LsRNAs for subregions R1, R2, R3 within rpoB gene. With genomic DNA, detection limits are 50 fg/reaction (∼10 copies) for mpb64 and 500 fg/reaction (∼100 copies) for rpoB. The assay reliably identified clinically dominant rpoB mutations (Leu511Pro, Asp516Gly, His526Tyr, Ser531Leu) and low-prevalence variants (Ser522Met, His526Arg, Leu533Pro). For cultured isolates, TB-SCANER was 100% concordant with Sanger sequencing for RIF resistance mutation profiling; in clinical samples, it matched Xpert for MTB detection (100%), outperformed culture sensitivity (100% vs. 93.8%), and was fully concordant with Sanger sequencing for RIF resistance, eliminating Xpert's false-positive while identifying all resistant strains. Collectively, TB-SCANER is a rapid, accurate, low-cost, one-pot CRISPR diagnostic that overcomes multiplexing barriers, enabling concurrent MTB detection and RIF resistance profiling particularly in resource-limited settings, and features built-in adaptability to other pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisRifampinDrug Resistance, BacterialBiosensing TechniquesTuberculosisHumansCRISPR-Cas SystemsBacterial ProteinsAntibiotics, AntitubercularMutationLimit of DetectionDNA-Directed RNA Polymerases

Stichwörter der Autor:innen

CRISPR-Cas12aCis-cleavageMycobacterium tuberculosisRifampicin resistanceTuberculosis

Substanzen

RifampinBacterial ProteinsrpoB protein, Mycobacterium tuberculosisAntibiotics, AntitubercularDNA-Directed RNA Polymerases

Autor:innen und Institutionen

  • Key Laboratory of Medical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China; Laboratory of Bacterial Disease, Experimental Center…
  • The Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, PR China.
  • Key Laboratory of Medical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
  • Laboratory of Bacterial Disease, Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, 550004, PR China; School of Public Health, The Key Laboratory of Environmental Pollut…
  • Laboratory of Bacterial Disease, Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, 550004, PR China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Chongqing Medical University, Chongqing, 400016, PR China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing Municipality
  • Science and Technology Planning Project of Yuzhong District of Chongqing City

Zitieren

APA

Yang, X., Zeng, X., Qi, G., Wang, J., Wei, X., Hu, Q., Huang, J., Chen, Y., Xie, Y., Li, Y., Zhong, Y., Li, S., & Yang, X. (2027). Unified hybrid RNA-regulated CRISPR diagnostic for concurrent Mycobacterium tuberculosis detection and rifampicin resistance profiling. Biosensors and Bioelectronics, 316, 119329. https://doi.org/10.1016/j.bios.2026.119329

Vancouver

Yang X, Zeng X, Qi G, Wang J, Wei X, Hu Q, et al. Unified hybrid RNA-regulated CRISPR diagnostic for concurrent Mycobacterium tuberculosis detection and rifampicin resistance profiling. Biosensors and Bioelectronics. 2027;316:119329. doi:10.1016/j.bios.2026.119329

BibTeX
@article{Yang2027,
  author = {Yang, Xinggui and Zeng, Xiaoyan and Qi, Guorong and Wang, Jiangfei and Wei, Xiaoyu and Hu, Qianfang and Huang, Junfei and Chen, Yijiang and Xie, Yaxing and Li, Ying and Zhong, Yuting and Li, Shijun and Yang, Xiaolan},
  title = {Unified hybrid RNA-regulated CRISPR diagnostic for concurrent Mycobacterium tuberculosis detection and rifampicin resistance profiling},
  journal = {Biosensors and Bioelectronics},
  year = {2027},
  volume = {316},
  pages = {119329},
  doi = {10.1016/j.bios.2026.119329}
}
Kostenlos starten →